The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland
Crossref DOI link: https://doi.org/10.1007/s40273-016-0430-z
Published Online: 2016-07-16
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nagy, Lisa
Heikkinen, Terho
Sackeyfio, Alfred
Pitman, Richard
Funding for this research was provided by:
AstraZeneca
License valid from 2016-07-16